Latest Issue of Advances in Hematologic Malignancies
Advances in Hematologic Malignancies is an e-newsletter written by Dana-Farber clinicians for hematologic oncology professionals nationwide.
The e-newsletter provides biannual updates from our experts on:
Issue 21, Fall 2025: Leukemia
Issue 20, Winter 2025: Multiple Myeloma and Other Plasma Cell Disorders
Issue 19, Spring 2024: Stem Cell Transplant and Cellular Therapies
Issue 18, Winter 2024: Early Detection and Interception of Blood Cancers
Issue 17, Winter 2023: Leukemia
Issue 16, Summer 2022: Lymphoma and CLL
Issue 15, Winter 2022: Multiple Myeloma
Issue 14, Spring 2021: Cellular Therapies
Issue 13, Winter 2021: ASH 2020 Highlights
Issue 12, Summer 2020: Leukemia
Issue 11, Fall 2019: Lymphoma and CLL
Issue 10, Spring 2019: Multiple Myeloma
Issue 9, Fall 2018: Precursor Conditions, NK Cell Therapy, MDS
Issue 8, Spring 2018: Collaborations
Issue 7, Fall 2017: Hematologic Malignancies
Issue 6, Spring 2017: Older Adults with Hematologic Malignancies
Issue 5, Fall 2016: Immunotherapy for Hematologic Malignancies
Issue 4, Summer 2016: Leukemia
Issue 3, Spring 2014: Stem Cell Transplant
Issue 2, Fall 2013: Multiple Myeloma
Issue 1, Spring 2013: Lymphoma
If you are a clinician specializing in the field of hematologic oncology, we can help you refer a patient, explore open clinical trials, learn about continuing medical education (CME) events, and more.
inpatient Transfer 857-215-3262
View our full list of hematologic malignancies resources for referring providers.
Questions or Comments?
